All blog posts
Showing 36 out of 72 results
19 February 2024
Five Years of Activity in a Priority Sector: The European Commission's Report on Competition Enforcement in the Pharmaceutical Sector (2018-2022)
01 February 2024
With the Headquarters Agreement for the Milan seat concluded, we look at the role of the UPC central division
12 January 2024
The UPC – 2023's achievements and predictions for 2024
06 December 2023
Competition law and biosimilars: Time for a new approach or not yet?
28 November 2023
Cyber security: Pharmaceutical companies on alert
01 November 2023
Another chapter in the "pay for delay" saga: General Court rules on the Teva-Cephalon settlement agreement
22 September 2023
Recent additions to Life Sciences Notes
22 September 2023
The UK National Security and Investment regime: spotlight on pharma M&A
13 July 2023
Navigating Contract Research Organisation Agreements: A legal perspective
05 June 2023
HSF comments to JUVE Patent on expectations and aspirations for the UPC
01 June 2023
The Unified Patent Court (UPC) starts today - 1 June 2023
19 May 2023
HSF comments for Managing IP on Milan UPC Central Division confirmation
Showing 36 out of 72 results
View moreKey contacts
Laura Orlando
Italy Managing Partner, Joint Global Head of Intellectual Property, EMEA Co-Head of Life Sciences, Milan